Cargando…

Differential and Overlapping Effects of 20,23(OH)(2)D3 and 1,25(OH)(2)D3 on Gene Expression in Human Epidermal Keratinocytes: Identification of AhR as an Alternative Receptor for 20,23(OH)(2)D3

A novel pathway of vitamin D activation by CYP11A has previously been elucidated. To define the mechanism of action of its major dihydroxy-products, we tested the divergence and overlap between the gene expression profiles of human epidermal keratinocytes treated with either CYP11A1-derived 20,23(OH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slominski, Andrzej T., Kim, Tae-Kang, Janjetovic, Zorica, Brożyna, Anna A., Żmijewski, Michal A., Xu, Hui, Sutter, Thomas R., Tuckey, Robert C., Jetten, Anton M., Crossman, David K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213311/ https://www.ncbi.nlm.nih.gov/pubmed/30297679 http://dx.doi.org/10.3390/ijms19103072

Ejemplares similares

Investigation of 20S-hydroxyvitamin D(3) analogs and their 1α-OH derivatives as potent vitamin D receptor agonists with anti-inflammatory activities
por: Lin, Zongtao, et al.
Publicado: (2018)

Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)(2)D, but No Difference in Ratio of 25(OH)D/24,25(OH)(2)D and FGF23 Concentrations
por: Vlot, Mariska C, et al.
Publicado: (2019)

Modulation by 17,20S(OH)(2)pD of Fibrosis-Related Mediators in Dermal Fibroblast Lines from Healthy Donors and from Patients with Systemic Sclerosis
por: Brown Lobbins, Monica L., et al.
Publicado: (2021)

17,20S(OH)(2)pD Can Prevent the Development of Skin Fibrosis in the Bleomycin-Induced Scleroderma Mouse Model
por: Brown Lobbins, Monica L., et al.
Publicado: (2021)

25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)(2)D(3)
por: Chiang, Kun-Chun, et al.
Publicado: (2016)

Association of Dietary Vitamin D Intake, Serum 25(OH)D(3), 25(OH)D(2) with Cognitive Performance in the Elderly
por: Wang, RuTong, et al.
Publicado: (2021)

Association among plasma 1,25(OH)(2)D, ratio of 1,25(OH)(2)D to 25(OH)D, and prostate cancer aggressiveness
por: Ramakrishnan, Swathi, et al.
Publicado: (2019)

Antidepressants differentially related to 1,25-(OH)(2) vitamin D(3) and 25-(OH) vitamin D(3) in late-life depression
por: Oude Voshaar, R C, et al.
Publicado: (2014)

Does Sevelamer Hydrochloride (Renagel) Influence 25(Oh)D3 and 1,25(Oh)2D3 Level in Haemodialysis Patients?
por: Strózecki, Pawel, et al.
Publicado: (2005)

25(OH)D(3) and 1.25(OH)(2)D(3) inhibits TNF-α expression in human monocyte derived macrophages
por: Rafique, Aisha, et al.
Publicado: (2019)

Effects of 1,25(OH)(2)D(3) and 25(OH)D(3) on C2C12 Myoblast Proliferation, Differentiation, and Myotube Hypertrophy
por: van der Meijden, K., et al.
Publicado: (2016)

25(OH)D status: Effect of D(3) supplement
por: Lukaszuk, J. M., et al.
Publicado: (2017)

25(OH)D(2) Half-Life Is Shorter Than 25(OH)D(3) Half-Life and Is Influenced by DBP Concentration and Genotype
por: Jones, K. S., et al.
Publicado: (2014)

20-Hydroxycholecalciferol, Product of Vitamin D3 Hydroxylation by P450scc, Decreases NF-κB Activity by Increasing IκBα Levels in Human Keratinocytes
por: Janjetovic, Zorica, et al.
Publicado: (2009)

Quantitation of serum 25(OH)D2 and 25(OH)D3 concentrations by liquid chromatography tandem mass spectrometry in patients with diabetes mellitus
por: Lin, Yi-Ching, et al.
Publicado: (2018)

The 25(OH)D3, but Not 1,25(OH)2D3 Levels Are Elevated in IBD Patients Regardless of Vitamin D Supplementation and Do Not Associate with Pain Severity or Frequency
por: Zielińska, Anna, et al.
Publicado: (2021)

Validation and Determination of 25(OH) Vitamin D and 3-Epi25(OH)D3 in Breastmilk and Maternal- and Infant Plasma during Breastfeeding
por: Gjerde, Jennifer, et al.
Publicado: (2020)

Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)(2)D(3)
por: Kägi, Larissa, et al.
Publicado: (2018)

Simultaneous determination of vitamin D metabolites 25(OH)D(3) and 1α,25(OH)(2)D(3) in human plasma using liquid chromatography tandem mass spectrometry
por: Xu, Shan, et al.
Publicado: (2022)

Oh-Oh-Ah-Ah-Rh ... ] Object Oriented Approach for ATLAS Reconstruction
por: Nevski, P
Publicado: (1993)

Efficacy of two vitamin D immunoassays to detect 25-OH vitamin D2 and D3
por: Garnett, Emily, et al.
Publicado: (2019)

Evaluation of Serum Level of FGF23 and 1,25(OH)(2)D(3) in Primary Hyperparathyroidism Patients Before and After Parathyroidectomy
por: Hassani, Solmaz, et al.
Publicado: (2020)

Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites
por: Dai, Bing, et al.
Publicado: (2012)

Lower placental 25-hydroxyvitamin D(3) (25(OH)D(3)) and higher placental CYP27B1 and 25(OH)D(3) ratio in preterm birth
por: Irwinda, Rima, et al.
Publicado: (2020)

Predictors of 25(OH)D half-life and plasma 25(OH)D concentration in The Gambia and the UK
por: Jones, K. S., et al.
Publicado: (2014)

Without 1α-hydroxylation, the gene expression profile of 25(OH)D(3) treatment overlaps deeply with that of 1,25(OH)(2)D(3) in prostate cancer cells
por: Susa, Takao, et al.
Publicado: (2018)

Metabolic Advantage of 25(OH)D(3) versus 1,25(OH)(2)D(3) Supplementation in Infantile Nephropathic Cystinosis-Associated Adipose Tissue Browning and Muscle Wasting
por: Zhou, Ping, et al.
Publicado: (2022)

Vitamin D (1,25(OH)(2)D3) induces α-1-antitrypsin synthesis by CD4(+) T cells, which is required for 1,25(OH)(2)D3-driven IL-10
por: Dimeloe, Sarah, et al.
Publicado: (2019)

Vitamin D and 1,25(OH)(2)D Regulation of T cells
por: Cantorna, Margherita T., et al.
Publicado: (2015)

The metabolism of 1,25(OH)(2)D(3) in clinical and experimental kidney disease
por: Turner, Mandy E., et al.
Publicado: (2022)

MON-LB74 The Problem of Measuring 1,25(OH)2 Vitamin D in Patients With High Levels of 25(OH) Vitamin D
por: Vieira, Jose Gilberto, et al.
Publicado: (2020)

Circulatory 25(OH)D and 1,25(OH)(2)D as differential biomarkers between multiple system atrophy and Parkinson's disease patients
por: Ogura, Hiromu, et al.
Publicado: (2021)

25(OH)D-but not 1,25(OH)(2)D–Is an independent risk factor predicting graft loss in stable kidney transplant recipients
por: Zeng, Shufei, et al.
Publicado: (2023)

Properties and Microstructure of Na(2)CO(3)-Activated Binders Modified with Ca(OH)(2) and Mg(OH)(2)
por: Xie, Lilan, et al.
Publicado: (2022)

Flame-Retardant Performance Evaluation of Functional Coatings Filled with Mg(OH)(2) and Al(OH)(3)
por: Piperopoulos, Elpida, et al.
Publicado: (2022)

Galectin-3 Contributes to the Inhibitory Effect of lα,25-(OH)(2)D(3) on Osteoclastogenesis
por: Gu, Jianhong, et al.
Publicado: (2021)

25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study
por: Ratzinger, Franz, et al.
Publicado: (2017)

Replacement of Oxygen by Sulfur in Small Organic Molecules. 3. Theoretical Studies on the Tautomeric Equilibria of the 2OH and 4OH-Substituted Oxazole and Thiazole and the 3OH and 4OH-Substituted Isoxazole and Isothiazole in the Isolated State and in Solution
por: Nagy, Peter I.
Publicado: (2016)

1,25-Dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)(2)D(3) in NSCLC Treatment
por: Upadhyay, Santosh Kumar, et al.
Publicado: (2013)

Generation and Applications of the Hydroxide Trihydrate Anion, [OH(OH(2))(3)](−), Stabilized by a Weakly Coordinating Cation
por: Weitkamp, Robin F., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0tih20tjnvp4rk2rdujq46ngg9